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ABSTRACT
DNA methylation is an important epigenetic modifi-
cation for genomic regulation in higher organisms
that plays a crucial role in the initiation and progres-
sion of diseases. The integration and mining
of DNA methylation data by methylation-specific
PCR and genome-wide profiling technology
could greatly assist the discovery of novel candidate
disease biomarkers. However, this is difficult
without a comprehensive DNA methylation reposi-
tory of human diseases. Therefore, we have
developed DiseaseMeth, a human disease methyla-
tion database (http://bioinfo.hrbmu.edu.cn/
diseasemeth). Its focus is the efficient storage and
statistical analysis of DNA methylation data sets
from various diseases. Experimental information
from over 14000 entries and 175 high-throughput
data sets from a wide number of sources have
been collected and incorporated into DiseaseMeth.
The latest release incorporates the gene-centric
methylation data of 72 human diseases from a
variety of technologies and platforms. To facilitate
data extraction, DiseaseMeth supports multiple
search options such as gene ID and disease name.
DiseaseMeth provides integrated gene methylation
data based on cross-data set analysis for disease
and normal samples. These can be used for
in-depth identification of differentially methylated
genes and the investigation of gene–disease
relationship.
INTRODUCTION
DNA methylation is one of the enzymatic modiﬁcations
in mammalian genomes (1,2). The methylated cytosines
are almost exclusively in a CpG dinucleotide sequence.
DNA methyltransferases (DNMTs) are the main enzymes
that catalyze CpG methylation. DNA methyltransferase 1
(DNMT1) is responsible for the post-replicative copying
of preexisting CpG methylation patterns, while DNMT3A
and DNMT3B are responsible for de novo DNA methy-
lation (3). Previous studies suggested that DNA methyla-
tion abnormality is one of the most frequent epigenetic
events in human diseases, and DNA methylation
patterns in disease tissue are different from those in their
normal counterparts (4,5). Aberrant hypomethylation
may lead to genome instability, transcriptional activation
of oncogenes, loss of imprinting, while hypermethylation
in local regions may be related to the selective advantage
for cancer cells (6–8). Because of the important
roles of promoter methylation in functional regulation,
DNA methylation has been studied extensively in
diseases such as neurodevelopmental disorders,
neurodegenerative and neurological diseases, autoimmune
diseases and cancers. Some important cases have been
reported, they include neprilysin (NEP) in Alzheimer’s
disease, frataxin (FXN) in Friedreich’s ataxia (9),
survival of motor neuron (SMN2) in spinal muscular
atrophy (9), methylguanine-DNA methyltransferase
(MGMT) in colorectal cancer (5,10), prolactin receptor
(PRLR) in breast cancer (11), methyl CpG binding
protein (MeCP2) in Rett syndrome (12) and imprinting
controlled region at 15q11–q13 in Prader–Willi and
Angelman syndromes (13).
Locus-speciﬁc approaches, like methylation speciﬁc
PCR, pyrosequencing and bisulﬁte sequencing, were
widely used in laboratories. Recently, high-throughput
approaches based on array and next-generation
sequencing for genome-wide analysis have been favored
(14). A collection of the disease methylation data
produced by these techniques will be useful and could be
used to explore the potential methylation markers/pheno-
types from whole methylomes in human disease states.
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bases, experimental evidence databases and large-scale
databases. The earlier methylation databases include
MethDB (15), MethPrimerDB (16), MethCancerDB
(17), PubMeth (18) and MeInfoText (19). MethDB
holds information about the occurrence of methylated
cytosines in the DNA assay information obtained
from multiorganism CpG methylation analysis.
MethPrimerDB stores conﬁrmed primer and experimental
information on four PCR methods for CpG methylation
analysis. MethCancerDB provides documentation of
pre-existing information regarding DNA methylation
in various cancers that includes study size, type of
cancer and method used. PubMeth and MeInfoText
are based on text-mining of Medline/PubMed abstracts
to extract information on methylation in cancer.
In contrast to these databases, there are two large-
scale methylation databases MethyCancer (20) and
NGSmethDB (21). MethyCancer hosts large-scale methy-
lation reference data, cancer-related genes and cancer
information from public data sources. NGSmethDB
hosts several sequence-based reference methylation data
sets that can be used to gain gene speciﬁc and differential
methylation information. However, there is a need for a
database that can integrate the dispersed data and provide
a convenient way for in-depth data mining. To this end,
we developed DiseaseMeth to combine experimental
methylation information from loci-speciﬁc technologies
with inferred gene-centric methylation states from methy-
lation proﬁling technology.
Various laboratories have proﬁled the methylomes of a
few human diseases [breast cancer (22,23) and leukemia
(24,25)], producing data that could be integrated to gain
further knowledge. It should be possible to identify
differentially methylated genes in diseases by integrating
data sets of the same disease. Cross-data set analysis for
speciﬁc diseases is useful because it is difﬁcult and costly
for experimental biologists to discover potentially novel
genes/regions in diseases. Furthermore, results are often
contradictory and need further conﬁrmation.
To tackle these challenges, DiseaseMeth was developed
to store and mine data efﬁciently through a user-friendly
extraction interface. The current release of DiseaseMeth
incorporates 72 disease types. Moreover, DiseaseMeth
stores many reference methylation data sets derived
from normal tissues/cells that can be used to identify
aberrantly methylated genes, and genomic data such as
CpG islands, histone modiﬁcations and annotated genes.
In addition, DiseaseMeth provides: (i) search options
that can be used to statistically identify gene-centric
methylation differences, extract detailed information
of differentially methylated genes in disease compared
with normal tissue, and calculate the signiﬁcance
of a speciﬁc differentially methylated gene; (ii) tools to
calculate the correlation of DNA methylation with the
pairwise relationships of gene–gene, gene–disease and
disease–disease, which could help in the discovery of
disease-speciﬁc and disease-consistent genes/markers;
and (iii) a genome methylation browser and customized
views that display gene-centric disease methylation infor-
mation combined with genomic information on the
genomic scale. In brief, DiseaseMeth hosts comprehen-
sive disease methylation data and provides tools to
explore the relationships between diseases and DNA
methylation.
OVERVIEW AND DATA PROCESSING
DiseaseMeth includes literature-based experimental infor-
mation and large-scale methylation data. Over 14000
entries for experimental information were collected by
text mining from more than 25000 published paper of
DNA methylation research in PubMed. DiseaseMeth
also holds 175 large-scale methylation data sets for
50 diseases, which were primarily collected from various
websites and institutes, such as ArrayExpress, Gene
Expression Omnibus (GEO), UCSC. Detailed and
updated statistics of the number of disease types is
shown on the DiseaseMeth homepage. A summary of
the publications sourced and the links to the sites from
which the data were downloaded is maintained and
updated on the download page. The download page lists
detailed information about the data sets including name/
ID, disease, data analysis, publication link, experimental
platform, sample size and download link. For raw
high-throughput data, only information about methyla-
tion within the promoter region of RefSeq genes was
kept for analysis. We deﬁned the promoter region as the
region from 1.5kb upstream of the transcription start site
(TSS) to 500bp downstream of the TSS of RefSeq genes.
For data from assemblies other than the UCSC March
2006 human reference sequence (hg18, NCBI build 36.1),
we used the LiftOver tool from UCSC (26) to convert the
coordinates from other assemblies to hg18. Normalized
and standardized data (0–100%) was used directly.
Unnormalized data was transformed according to the
common procedures. All normalized methylation data
were subsequently transformed into a consistent interval
[0,100] by percentile normalization reﬂecting relevant
methylation levels before being ﬁnally stored. All data
available for download is stored in GFF (General
Feature Format) ﬁles. The basic operations in the
DiseaseMeth database are search, view, download and
analyze (Figure 1). A ﬂexible search engine based on a
MySQL backend is provided to allow user-friendly data
mining and downloading. The methylation information in
DiseaseMeth with a few other annotations can be viewed
using the visualization module based on the Perl
Bio::Graphics package.
DATABASE USAGE AND ACCESS
Using the search tool to retrieving the methylation states
of promoters
All methylation states for a given chromosomal region
can be retrieved, when the start and end chromosome
coordinates are provided. The data for a selected
disease, tissue, cell line, technology and gene ID can also
be retrieved. The more query parameters that are provided
the narrower the range of the entries that are
retrieved. A valid RefSeq ID (NM*) or an ofﬁcial gene
Nucleic Acids Research, 2012,Vol. 40,Database issue D1031symbol is needed to obtain the gene-centric methylation
information. The output is displayed by default as an
overview table that summarizes the methylation states of
the genes and gives disease and other information. The
table contains links to generate gene-centric methylation
information panels for disease and normal samples based
on the speciﬁed search parameters. As an example, we
analyzed the promoter region of the gene RASSF1
(Figure 2). The results show that the promoter of the
transcript is differentially methylated between the disease
and control states. To facilitate viewing genes and other
relevant information, gene-speciﬁc links to other resources
such as the GeneCards database are displayed in the
overview panel and in the gene-centric information
table. The full results of a query can be downloaded
from a link in the overview panel.
Genomic methylation viewer
DiseaseMeth includes a user-friendly and conﬁgurable
genome browser through which multiple genomic and
epigenomic resources can be visualized simultaneously
(Figure 2). The genomic methylation viewer connecting
to a MySQL backend is used to show the methylation
landscape for disease methylation information, other
genomic annotations [GC content, genes and CpG
islands (27)] and epigenomic information (methylation
data sets and histone modiﬁcations). Features of the
viewer include the ability to zoom through the given
regions, to enter a region by specifying the genomic
coordinates, to change the order of tracks and to show
and hide certain feature tracks and conﬁgure the appear-
ance of the displayed information. Currently, a few
epigenomic tracks can be conﬁgured in the viewer:
(i) HAIB RRBS tracks from ENCODE/HudsonAlpha
tracks; (ii) RRBS tracks from BI Human Reference
Epigenome Mapping Project; (iii) MeDIP-chip; (iv)
MeDIP-seq; and (v) Histone modiﬁcation. In the viewer,
the methylation values do not indicate strand-speciﬁc
information. A color gradient from white (methylation
value=0) to red (methylation value=100) is used to
display the numeric methylation states of the cytosines/
regions. The browser can also link out to other epigenomic
databases such as MethyCancer (20) and HHMD (28).
Analysis tools to explore the relationships between
genes and diseases
In disease, a few genes, including tumor suppressor genes,
are silenced by promoter CpG island methylation (13).
However, only a subset of colorectal cancers has been
documented as exhibiting promoter methylation and is
referred to as the CpG island methylator phenotype
(CIMP) (29). In addition, gene–gene and disease–disease
relationships have been characterized using available gene
expression data (30). Because the availability of DNA
methylation data is low, it is inefﬁcient to analyze the re-
lationships of genes and diseases using DNA methylation.
However, with the data stored in DiseaseMeth, it is easy
to determine a preliminary proﬁle of the relationship
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Figure 1. Overview of structure and workﬂow of DiseaseMeth. Users can input Refseq ID, Gene symbol or genomic position to the query engine
to gain the methylation pattern of these regions in different samples. The terms imported by users would be transformed into the genomic coord-
inates which are further used to search the relational database of DiseaseMeth. Users also can restrict the disease type. The query results can
be viewed in the gene-centric result viewer, and downloaded as ﬂat format. The relationship analysis of module is provided for users to investigate
the relationships among genes and diseases.
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that have been developed: (i) disease–gene relationship
analysis tool; (ii) disease–disease relationship analysis
tool; and (iii) gene–gene relationship analysis tool. One
of the merits of these tools is that they are highly custom-
izable for analyzing given regions, diseases and so on;
thus, facilitating speciﬁc analysis focusing on continuous
regions such as imprinting clusters (31). The three analysis
tools are available for download.
SYSTEM DESIGN AND IMPLEMENTATION
DiseaseMeth consists of three major software compo-
nents: an Apache HTTP server, a MySQL database and
a Perl installation using the Bio::Perl, Bio::Graphics and
DBI packages. The backend data analysis programs were
written in Perl and deployed as CGI programs. The Perl
programs for the analysis tools are available on the
website.
FUTURE DEVELOPMENT
To build a DNA methylation database focusing on human
diseases, continued efforts will be made to update the
DiseaseMeth data and improve the genomic methylation
viewer and database functionality. As the DNA methyla-
tion data becomes available, we will continuously collect
the latest disease data sets to keep DiseaseMeth
up-to-date. Because of the usefulness of reference methy-
lation maps in human DNA methylation analysis, we will
include more methylation maps of normal cell lines/tissues
in DiseaseMeth to help with comparative studies of
Figure 2. A screen shot of the DiseaseMeth search results for the gene RASSF1. The default view generated by the search tool is shown.
Clicking the ‘Fetch gene-centric information of all genes’ button in the toolbar displays the gene-centric results, where the gene ID, gene Name,
methylation level (from 0% to 100%), the number of relevant data in the database, and the signiﬁcance of the methylation difference between disease
and normal data sets for the genes are shown. In addition, the relevant reference links are also included in the overview panel. Concurrent searching
of multiple genes is supported. In the gene-centric panel, a link (Visualization) is available to display the epigenomic data in the genomic context.
There is also a ‘Visualize a selected gene’ button in the toolbar in the default view that does the same task. The whole of the search results can be
downloaded by clicking the ‘Download all’ button in the toolbar.
Nucleic Acids Research, 2012,Vol. 40,Database issue D1033disease-speciﬁc from normal methylomes. We will develop
new data processing algorithms to handle the large-scale
nature of DNA methylation sequencing data. Because of
the importance of integrative analysis, we will regularly
collect data from new sources to enhance the analytical
depths of DiseaseMeth. We will also encourage new
data to be submitted directly to DiseaseMeth to keep
DiseaseMeth updated and to make it comprehensive.
The genomic methylation viewer will be improved to
display more (epi)genomic resources and will be
extended to include more conﬁgurable functionalities.
Finally, novel analysis tools will be developed to provide
better integration and to enhance the data mining
capabilities. As a resource to study the potential regula-
tory function of DNA methylation, DiseaseMeth can
be extended to include more data sets and tools can
be developed for the identiﬁcation of disease-related
DNA methylation markers for candidate genes using
an integrated differential methylation identiﬁcation
algorithm (32). We expect that the continuous efforts to
use and improve DiseaseMeth will contribute to our
understanding of DNA methylation driven human
diseases.
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